Literature DB >> 2986876

Platelet activation and secretion associated with emotional stress.

S P Levine, B L Towell, A M Suarez, L K Knieriem, M M Harris, J N George.   

Abstract

Platelets are believed to play a role in the pathogenesis of atherosclerosis and of the vascular obstruction that causes the acute complications of coronary artery disease. Since specific behavioral patterns appear to be related to the development of coronary artery disease and since emotional stress may predispose an individual to acute cardiovascular ischemia, it was hypothesized that platelet activation by catecholamines might be involved in these events. To study emotional stress, plasma samples were obtained from 61 senior medical residents immediately before they were to speak in public. There were significant increases in the plasma concentrations of the platelet-secreted proteins platelet factor 4 and beta-thromboglobulin and epinephrine and norepinephrine immediately before speaking, which demonstrates that platelet activation and secretion occur in association with this type of emotional stress. Four trials were carried out to study the mechanism for this observed platelet secretion: (1) phenoxybenzamine, (2) propranolol, (3) 650 mg aspirin, and (4) 80 mg aspirin were given several hours before the public speaking engagement. Neither phenoxybenzamine nor propranolol in doses that blocked the hemodynamic effects of alpha 1- and beta 1-adrenergic stimulation modified platelet secretion. Aspirin also did not block platelet secretion, which suggests that platelets were not being stimulated through a cyclooxygenase-dependent pathway. This study provides direct evidence of platelet secretion in vivo in association with emotional stress, and underscores the potential importance of platelet activation and secretion in the acute events that occur in patients with vascular disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986876     DOI: 10.1161/01.cir.71.6.1129

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

Review 1.  Brain, behavior, mental stress, and the neurocardiac interaction.

Authors:  Robert Soufer; James A Arrighi; Matthew M Burg
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

Review 2.  Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease?

Authors:  Wei Jiang; Ranga R Krishnan
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

3.  Editor's page: fundamentals in neurocardiology: the brain-platelet-coronary artery interface.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-07-20       Impact factor: 2.300

4.  Life events and difficulties preceding stroke.

Authors:  A House; M Dennis; L Mogridge; K Hawton; C Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

Review 5.  Unstable angina.

Authors:  D L Patterson
Journal:  Postgrad Med J       Date:  1988-03       Impact factor: 2.401

6.  Relation between psychological strain and carotid atherosclerosis in a general population.

Authors:  B Wolff; H J Grabe; H Völzke; J Lüdemann; C Kessler; J B Dahm; H J Freyberger; U John; S B Felix
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

Review 7.  Psychosocial stress and cardiovascular disease: pathophysiological links.

Authors:  C Noel Bairey Merz; James Dwyer; Cheryl K Nordstrom; Kenneth G Walton; John W Salerno; Robert H Schneider
Journal:  Behav Med       Date:  2002       Impact factor: 3.104

8.  The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.

Authors:  Jeff C Huffman; Christopher M Celano; James L Januzzi
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

9.  Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation.

Authors:  P T Larsson; G Olsson; B Angelin; E Granström; G Hansson; P Hjemdahl
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 10.  Anxiety Disorders and Cardiovascular Disease.

Authors:  Christopher M Celano; Daniel J Daunis; Hermioni N Lokko; Kirsti A Campbell; Jeff C Huffman
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.